ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Explore key tips on what not to do when planning for retirement. Avoid common missteps to ensure a successful retirement.
26,407 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
United Wholesale Mortgage reports a profitable first quarter as originations slow. CEO Mat Ishbia escalates pressure ...
A clear, investor-friendly breakdown of Primoris' Q1 2026 earnings. Learn what drove results, how to read backlog and...
Sportradar is at a pivotal moment as 2026 earnings unfold. This guide breaks down the numbers, the drivers behind gro...
A sharp divergence in the online brokerage space emerges in 2026 as Robinhood declines while Interactive Brokers gain...
XRP sits in a tight range around $1.40 as analysts map the path to a potential break all-time high this year. The out...
Stocks all-time highs still attract buyers as earnings momentum and AI-driven demand support another leg up. Here's t...
A speculative bid by GameStop to purchase eBay sparks fresh debate about stock-based deals and the risk of overpaying...
Upstart stock has taken a hard one-way trip downward, leaving some investors wondering if a rebound is possible. This...
Circle announces a $222 million Arc token presale at a $3 billion FDV, drawing major investors as quarterly revenue g...
UBS is moving to absorb Credit Suisse, ending a years-long saga of espionage, talent raids, and legal clashes. The de...
When bad news hits a stock, investors ask if it’s a bargain. This piece weighs UPS’s challenges against its resilient...